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Lyme Disease Essentials for Healthcare Workers
Chapter 1: Introduction and Background
Background and Clinical Significance
Since Lyme disease (LD) was identified nearly fifty years ago, it has caused illness
throughout the United States (U.S.), Europe, and Asia. In the U.S., LD is the most common
vector-borne infectious disease and is spread through the bite of an infected tick (Lo et al., 2004).
Lyme disease is caused by the bacteria “Borrelia burgdorferi” and most commonly is
transmitted by the black-legged tick, often referred to as the deer tick (Marchese & Primer,
2013). Ticks and Lyme disease have been present for thousands of years. Mitochondria DNA
analyzed from Otzi, the oldest known European mummy, revealed that the bacteria that caused
LD resided deep within his bones (Vollick, 2017). However, LD was only recognized in the U.S.
in the 1970s, and the bacteria was not classified until 1981 (Bay Area Lyme Foundation, 2020).
In the early 1970s, residents who lived around Lyme Connecticut were suffering from
debilitating health issues. Their symptoms included swollen knees, paralysis, skin rashes, and
severe fatigue, and they were left undiagnosed and untreated for many years. Two mothers
sought medical help and reached out to the Yale School of Medicine and the Connecticut State
Department of Health. Their actions sparked an investigation that led to the characterization of
what is now known as Lyme disease (Elbaum-Garfinkle, 2011). Without the advocacy of these
mothers, there still might be little known about LD even today.
The initial clinical presentation of LD is similar to many common viral illnesses, which
often makes it difficult for healthcare providers to diagnose. Regardless of clinical presentation,
most patients with LD have resolution of their symptoms if treated with appropriate antibiotics
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(Bratton et al., 2008). If incorrect diagnoses or failure to seek treatment occur, there is potential
for more severe symptoms that can affect the entire body (Elflein, 2019).
Contributing Factors of Lyme Disease.
Geographical Location
Although initially in the northeastern section of the U.S., Lyme disease has significantly
widened to nearly every state (CDC, 2018b). The increase in the geographical spread of LD is
multifactorial. Still, studies suggest an increase in the deer population and a decrease in small
animal predators as the key factors in spreading and transmitting Lyme and other tick-borne
diseases (Kugeler et al., 2015). Even with the geographical expansion of Lyme, the northeast
states such as Maine, Vermont, and Pennsylvania continue to experience the highest rate of
incidence (Elflein, 2019).
Peak Occurrence
The majority of LD cases appear in the early spring to summer months. Still, peak
occurrence can vary with geographical location from year to year due to meteorological and
climate changes (Moore et al., 2014). Peak occurrence may also be influenced by man. Spring
through early fall is typically the time when most humans are active outdoors. This increase in
activity can potentially augment or decrease the risk rate of exposure (Moore et al., 2014).
Prevalence
The risk of acquiring LD is more prevalent than ever. Currently, it is estimated that over
30,000 cases are reported yearly. Still, the true incidence of LD is complicated by inaccurate
reporting and the frequency of misdiagnosis (Murray & Shapiro, 2010). To improve public
health, the Center for Disease Control and Prevention (CDC) conducted two studies to determine
how many people each year are accurately diagnosed with Lyme disease by utilizing medical
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claims databases and commercial laboratory data. These studies suggest that the true incidence of
LD in the U.S. is around 300,000 cases per year (CDC, 2018a).
High Risk Population
People at an increased risk for tick bites spend time outdoors either by occupation or
leisure (APHA, 2015). The true incidence of occupationally acquiring LD is challenging to
determine due to the inability to pinpoint the exact time of exposure (OSHA, n.d.). Many those
diagnosed with a tick-borne disease cannot recall being bitten by a tick (OSHA, n.d.).
Problem Statement
Recognition of LD has been known to be problematic due to the commonality of the
symptoms it can exhibit. Referred to as the great imitator, LD can mimic many diseases and
affect every tissue and organ in the human body (Melia et al., 2014). Delays in diagnosis or
implementation of treatment modalities for LD can lead to multiple complications. With this
growing public health concern, healthcare providers should know the clinical symptoms and
consider LD as a differential diagnosis.
Multiple studies have examined the level of knowledge and perceptions that healthcare
providers have regarding LD. Results varied among the studies, but there appears to be a lack of
general knowledge. The majority of the studies examined practice patterns of physicians. Those
that included healthcare workers, registered nurses (RNs), and advanced practice registered
nurses (APRNs) in their study were noted to have less than robust knowledge scores of all
providers represented. To address this demonstrated gap, an educational webinar was created to
promote awareness and expand knowledge of LD.
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Research Question
What is the impact of a Lyme disease educational program on healthcare workers,
specifically registered nurses and advanced practice registered nurses? Will posttest scores be
significantly increased from pretest scores following a Lyme disease education program for both
RN and APRN providers?
Purpose of Project
The projects goals were to determine if RN and APRN healthcare workers who
participate in a Lyme disease educational program will demonstrate:
1. Knowledge of the epidemiology of Lyme disease in Tennessee.
2. Knowledge of the disease manifestations and course, including chronic complications
of Lyme disease.
3. Skill in the safe removal of an embedded tick.
4. Commitment to the evidence-based individual patient, family, and public education
about Lyme disease prevention and treatment.
5. Acquaintance with Lyme disease educational and referral resources.
Concepts and Definition of Terms
For the purpose of this scholarly project, the following terms listed below are involved in
distinctive characteristics of Lyme disease.
Lyme disease is a bacterial infection caused by Borrelia burgdorferi (BB), which can be
transmitted to both humans and animals through the bite of an infected black-legged, also known
as the deer tick (Sharareh et al., 2017).
Borrelia burgdorferi is a gram negative-like bacterium that is a member of the spirochete
family and, left untreated can migrate throughout the bloodstream and cause systemic infections
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(Hyde, 2017). The Lyme bacteria is transferred to both humans and animals from an infected tick
and can be transmitted in as little as 24 hours after attachment of the tick; however, there is an
increased risk associated with prolonged attachment (CDC, 2019a).
Erythema migrans (EM) refer to the most well-known sign of LD. EM is a red rash that
resembles a bull’s eye target and is considered diagnostic criteria (Moore, 2015). Erythema
migrans rash can occur anywhere on the body but typically are discovered in or by the axilla,
inguinal region, beltline, or popliteal fossa. The rash typically develops slowly over seven to
fourteen days around the tick bite area but may appear in as few as three days or as long as onemonth post tick exposure (Moore, 2015).
While EM is the hallmark sign for LD, the rash occurs in fewer than fifty percent of
individuals with confirmed serum diagnoses (Cameron et al., 2014). The typical presentation
associated with LD is the bulls-eye rash, but the EM rash can have a variation of appearances to
include bluish-red lesion, uniformly red, or without central clearing lesion (Hu, 2016).
Theoretical Framework
The theoretical framework chosen to guide this project is Jean Watson’s Theory of
Caring and the Adventist Framework for Nursing. Watson’s theory is based on four basic
understandings: human being, health, the environment, and nursing (Chantal, 2003). The
Adventist framework foundation is centered around the concepts of caring, empowering, and
connecting (Jones et al., 2017). These models can be used in the clinical and educational settings
to help nurses and advanced practice providers focus on disease prevention and health promotion
strategies.
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Fundamental concepts from these frameworks formed the basis for creating caring
relationships between the participants of this project included:
1. Promote professional growth in the healthcare workers by empowering the
participants with knowledge and resources needed to diagnose, treat and prevent
Lyme disease.
2. Be mindful that each human has their own set of beliefs and health practices. This
practice will allow the healthcare worker the opportunity to create an environment
that can nurture the physical and spiritual health of their patients.
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Chapter II- Literature Review
The effect of LD on health is an important topic. As the prevalence of LD increases,
educating both patients and healthcare providers about the impact of LD is an essential
component of promoting health. This literature review serves to provide healthcare workers with
the necessary tools that can enhance practice decisions and influence patients. Databases
searched for this study included the following sources: CDC, Cochrane, CINAHL, EBSCOhost,
Medline, and PubMed. Key search terms included: Black-legged tick, Borrelia burgdorferi, Deer
tick, Erythema migrans, Lyme disease, Lyme disease testing, and Prevention of Lyme disease.
Evidence
Clinical Features
Lyme disease is difficult to diagnose for many reasons. Many of the disease's associated
symptoms, such as fatigue, headache, dizziness, and joint/body pain, are also present with many
common illnesses (Eisen et al., 2012). As the disease progresses, the clinical signs and symptoms
will vary. Due to the lack of accurate and expedient diagnostic tests, many patients are diagnosed
based on the combination of presenting symptoms until confirmation of laboratory data is
available. With this in mind, the healthcare provider needs to perform an in-depth exam and
subjective review of history in all patients with high-risk activities and those who live in or have
traveled to high endemic areas (Meyerhoff et al., 2019).
Stages and Classification of Lyme Disease
Transmission of Lyme can only occur through a bite of an infected tick. In most cases,
the tick must be attached to its human host for greater than 24 hours before the gram-negative
bacteria can be transmitted (Bratton & Cory, 2005). After transmission has occurred, the bacteria
multiply at the tick bite site and migrate from the site to the surrounding tissue. As the bacteria
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expand, they spread through the blood and lymphatic systems to other organs (Marchese &
Pruner, 2013). To better understand the progression of this systemic illness, it has been classified
into three different stages to help providers further understand the disease (Sanchez et al., 2016).
Stage 1: Early localization. The initial stage of LD is often called early-localized disease
that occurs three to thirty days after tick exposure. The most common symptom present during
this stage is erythema migrans (EM), a red circular expanding rash often referred to as a bullseye. The CDC guidelines recommend that the rash/lesion diameter be at least five cm with an
average size of 15 cm to be considered EM in the appropriate clinical setting (Bratton et al.,
2008). The majority of patients who develop EM also have symptoms resembling a viral
infection, including arthralgia, fatigue, headache, neck pain, and fever, which may or may not be
present (Ziegler et al., 2013).
Stage 2: Early disseminated. If early localization is not recognized or is untreated,
B. burgdorferi enters the bloodstream and is spread throughout the lymphatic and hematologic
systems. This systemic spread has the potential for initiating multiple EM lesions and the
development of neurological and cardiac symptoms (Nichols & Windemuth, 2013). The most
common neurologic symptom is Bell’s palsy, but meningitis and paresthesia can also occur
(Ziegler et al., 2013). Cardiovascular symptoms include atrioventricular blocks, QT
prolongation, syncope, palpitations, and/or chest pain. Lyme myocarditis can be a lifethreatening manifestation but only occurs in one percent of patients with LD (CDC, 2019d).
Stage 3: Late disseminated. The late dissemination stage of Lyme can occur months to
years after the initial infection and may or may not be associated with a history of localized or
disseminated disease (CDC, 2019e). If LD is left untreated, 60% of patients develop late
dissemination (Arvikar & Steere, 2015). In this stage, the gram-negative bacteria have spread
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throughout the body, and many patients experience chronic arthritis in joints near the initial
infection point.
Post-Lyme Disease Syndrome
Currently, there is no accepted definition or diagnostic criteria for post-Lyme disease
syndrome (PTLDS), also known as chronic LD. The term applies to patients with otherwise
unexplained subjective symptoms lasting for more than six months after completion of
recommended antibiotic therapy (Bratton et al., 2008). Around 10% of patients experience
persistent symptoms such as fatigue, myalgia, arthralgia, mood and memory disturbances
(Scieszka et al., 2015). Some suggest that these persistent symptoms result from slowly resolving
inflammation; however, no studies have shown consistently elevated levels of serum
inflammatory markers (Bratton et al., 2008).
There is no proven treatment for PTLDS, and lengthy courses of antibiotics are not
recommended in these patients. Studies funded by the National Institutes of Health have found
that long-term outcomes are little or no better in patients who received prolonged antibiotic
treatment (CDC, 2019f). The use of prolonged antibiotic therapy for PTLDS tends to do more
harm than good, and most patients recover from the persistent symptoms associated with LD
with time (Scieska et al., 2015).
Diagnosis
Due to the variability of symptoms LD displays, it makes it challenging to diagnose since
available testing can be unreliable and nonspecific in the early stages of the disease. The
healthcare provider must consider the patient’s history, high-risk activities, signs and symptoms,
and serum laboratory studies. Every year, at least 3.4 million Lyme disease tests are performed,
presently the CDC recommends a two-step testing process for LD. Both steps are required to
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properly diagnose and can be done using the same serum blood sample. If the first step is
negative, no further testing is indicated. If the first test is positive, the second step should be
performed. If both tests are positive, then the accurate diagnoses of LD are equivocal (CDC,
2019b).
Key points to remember when evaluating for LD is that tests are designed to detect
antibodies made by the body in response to the infection. These antibodies can take several
weeks to develop; if performed too early it may render a false negative, and consequently further
testing is not considered or appropriate antibiotic treatment given. Early LD is a clinical
diagnosis based on exposure to a tick bite followed by EM rash within four weeks of exposure.
Antibodies can persist in the blood for months to years after the infection is gone; therefore,
these tests cannot be used to determine a cure (CDC, 2019b). False-positive results do occur if
the autoimmune disease lupus, HIV, or syphilis is present. Less frequent false-positive results
can happen if Helicobacter pylori bacteria or Epstein-Barr virus is present (Kling et al., 2015).
Treatment
When diagnosis and treatment are implemented in the early stages of LD, patients usually
recover rapidly and without residual symptoms. Treatment guidelines from the Infectious
Disease Society of America consist of oral antibiotics such as doxycycline, amoxicillin, or
cefuroxime. If neurological or cardiac involvement is present, treatment with intravenous
antibiotics such as ceftriaxone or penicillin may be warranted. Treatment modalities may be
adjusted based on the patient’s age, renal function, pregnancy status, or allergies (CDC, 2019e).
In high endemic areas, a single prophylactic dose of doxycycline may be used to reduce
the risk of acquiring Lyme after a prolonged bite exposure of 36 hours or more. It is
recommended that prophylaxis be initiated within 72 hours post-removal (Worsmer et al., 2006).
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Routine antibiotic prophylaxis is not recommended if the tick attachment is less than 36 hours
(CDC, 2019g). Prophylactic antibiotic treatment is not recommended for children and pregnant
women. All patients who have ticks removed, regardless of receiving prophylaxis, should closely
monitor for signs and symptoms of tick-borne disease for 30 days (Bratton et al., 2008).
Prevention Strategies
Avoidance of tick bites is the most apparent means of preventing in a tickborne illness.
An array of preventative measures can be initiated when participating in outdoor activities to
include: avoidance of tick habitats, tick repellents, DEET impregnated clothing, tick checks, and
proper removal of attached ticks (Vaughn & Meshnick, 2011).
Tick Habitats. Ticks like to be near the ground, leaf litter, tall grasses, and fallen logs.
High-risk activities such as playing in leaves, lying on the ground, gathering firewood, and
leaning against tree trunks should be avoided. When hiking or biking, it is recommended to stay
on cleared trails instead of traveling across grassy fields (CDC, 2020). Simple landscaping
techniques include mowing the lawn frequently, clearing tall grasses and brush around the home,
placing a three-foot-wide barrier of wood chips or gravel between lawn and wooded areas to
restrict tick migration, and constructing a fence to discourage unwelcomed animals (deer,
raccoons, and stray dogs) from entering the yard (CDC, 2020).
Proper Clothing. A recent study from the CDC revealed clothing treated with
insecticides could reduce the ability of migration from clothing to skin. Only 58% of ticks that
encountered fabric treated with 0.5% permethrin remained on the textile after one minute of
exposure (CDC, 2020). Permethrin is approved by the Environmental Protection Agency and is
safe to be used on clothing worn by adults and children but is not safe for topical application
(USEPA, n.d.). Other methods of protective clothing include wearing light-colored clothing, long
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sleeve shirts, long pants, socks, and close-toed shoes (CDC, 2020). When spending time in
wooded or high endemic areas, tucking pant legs into socks can hinder ticks from attaching to
the skin (Eisen et al., 2012).
Repellents. Topical repellents such as DEET can provide adequate personal protection
from tickborne diseases by deterring the attachment of ticks. Even though DEET is an effective
protective measure, only about 20% - 40% of individuals in high endemic areas use it on a
regular basis (Eisen et al., 2012). Currently there is a growing interest in a more natural approach
to prevention, but most are not recommended due to lack of effectiveness. The only plant-based
product that has shown to be effective and comparable to DEET is the oil of lemon eucalyptus,
but pregnant women or children less than three years of age should not use this product.
Essentials oils have not proven effective and are not recommended by the CDC (Yates, 2015).
After spending time outdoors, check your clothing for ticks and wash clothing in hot
water or put them in the dryer on high heat for 10 minutes to kill ticks. Cold or medium-hot
temperatures are less effective in killing ticks. Showering within two hours after being outdoors
has been shown to reduce the risk of getting a tick-borne disease (CDC, 2020).
Correct Tick Removal
Improper removal of ticks dramatically increases the risk of acquiring Lyme and other
tickborne infections. Manual extraction and topical application of household items such as
essential oils to make the tick detach and back out of the skin may be counterproductive and can
increase the chance of pathogen transmission (Marchese & Primer, 2013.
Proper removal of a tick includes avoiding touching the tick with bare hands, using a
fine-tipped tweezers to firmly grasp the tick as close to the skin as possible, with a steady motion
pull straight upwards until all embedded parts of the tick are removed. It is important not to
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twist, crush or jerk the tick as it may cause parts of the tick to break off in the skin (CDC,
2019h). If this occurs, use the tweezers and extract as much of the tick as possible. After
removal, thoroughly wash your hands and tick removal area with soap and water or an alcoholbased hand sanitizer. To dispose of a live tick, you can place it in alcohol, a sealed bag, or flush
it down the toilet. You should never attempt to kill a tick by crushing it with your fingers (CDC,
2019h).
Vaccination
In the U.S., there is no Federal Drug Administration (FDA) approved vaccine for Lyme
disease. In the early 1990s, the LYMErix vaccine was developed to prevent LD; however, poor
sales and negative publicity prompted the pharmaceutical company to voluntarily discontinue its
production (Nigroveic & Thompson, 2007). Valneva, a biotech company, has developed VLA15
vaccine that the U.S. FDA has granted Fast Track designation in 2017. It has reported positive
Phase 1 results with two planned parallel Phase 2 studies upcoming. Phase 2 will consist of an
observer-blind placebo-controlled trial conducted in both the U.S. and Europe. The results of
these studies, comprising immunogenicity and supporting safety data, will determine the dose
and vaccination schedule to be utilized in Phase 3 (Shaffer, 2019).
Provider Knowledge
A study by Singh et al. (2016) reported findings that indicated healthcare providers have
a good understanding of the etiology of LD. Of the articles included in this review, three main
categories relating to provider knowledge were concerning. Knowledge levels varied regarding
diagnostic testing, recognition of EM as diagnostic criteria, and inappropriate pharmaceutical
treatment.

19

Laboratory Testing
Current data suggest that clinicians are unaware of testing guidelines set forth by the
CDC. A 2011 cross-sectional mixed-methods nationwide survey of physicians and APRNs found
that most respondents answered correctly to basic knowledge of Lyme disease, but around 42%
incorrectly interpreted false-positive IgM results as overall positive in a patient with
longstanding symptoms (Conant et al., 2018). Singh et al. (2016) compared the knowledge of
West Virginia physicians of varying specialties and found 42% - 50% of providers incorrectly
interpreted a clinical scenario surrounding a patient with longstanding nonspecific symptoms and
negative test results. This study also examined if these providers followed the CDC
recommendation for two-tiered testing. The results were variable depending on the practice
specialty; however, only 27% - 47% of providers answered correctly (Singh et al., 2016).
Erythema Migrans
Multiple studies assessed health care provider knowledge of EM using clinical scenarios.
The study findings from West Virginia, Connecticut, and Arkansas indicated an overall low
percentage of physicians’ awareness that EM rash is a major diagnostic criterion for Lyme
disease (Bret et al., 2014). This alludes to a critical gap in provider knowledge of LD and the
basic symptomology and diagnostic criteria.
Antibiotics and Prophylaxis
Perea et al. (2015) evaluated tick-bite prophylaxis from a national survey of greater than
2000 healthcare providers, including primary care physicians, pediatricians, and nurse
practitioners. Over 56% of participants reported they had prescribed antibiotic prophylaxis at
least once during the previous year, including 73% of healthcare providers in high LD incident
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states and 48% in low LD incident states. The rationales for prophylaxis were to prevent Lyme
disease, patient request for antibiotic treatment, and prevent other tick-borne illnesses. Of the
healthcare providers who provided prophylaxis, nearly 45% felt that it was not clinically
warranted (Perea et al., 2015). Survey results from Arkansas primary care physicians showed
that 39% of providers-initiated antibiotics and tick-bite prophylaxis when they did not believe
LD was present, and 52% reported that patients often mentioned the possibility of LD as a
differential diagnosis (Hill & Holmes, 2014).
Conclusion
The literature review revealed knowledge gaps on diagnosis and prophylactic treatment
of LD by healthcare providers are present; however, the knowledge basis of APRNs and RNs is
not reported. Most of the available research assessed physician’s knowledge exclusively; studies
that solely evaluated APRNs and physician assistants (PAs) represented a small percentage of
the samples and studies. Remote studies in the late 1990s assessed RNs knowledge of LD;
however, recent studies have not incorporated these providers. The gap in the literature is
concerning, and further research should be explored to gain an understanding of healthcare
workers’ knowledge of LD.
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Chapter III- Project Description
Objectives and Design
After a comprehensive review of available literature, a knowledge gap was apparent. The
majority of available studies reviewed physicians' practice patterns; the studies that included
APRNs or PAs were a small subset of the reported study population. With this demonstrated gap
in knowledge, an online educational webinar was created with the intent to focus on education of
Lyme disease for RN and APRN healthcare workers (Appendix A). The quantitative pretestposttest design of this study examined if the educational webinar results in an increased
knowledge of LD in healthcare workers.
Procedures
Description of Procedures
The target audience of this study was RN and APRN healthcare workers who were
interested in enhancing their knowledge of LD. The educational webinar consisted of a recorded
voice-over PowerPoint presentation containing the most current evidence-based information with
photos and images from the CDC. Permission was obtained from the CDC for the usage of text,
graphs, and images (Appendix B & C). The webinar incorporated a brief overview of this
scholarly project, history of Lyme disease, signs and symptoms, preventative measures, effective
removal techniques, and a link to Survey Monkey for a baseline evaluation of knowledge and
post-webinar assessment of knowledge. The webinar link and description of the project with
participant consent (Appendix D) was posted to the various social media sites that are frequented
by nurses and posted once a week for four weeks. The link was active for 30 days. Permission
was obtained from the chosen web group sites before posting the webinar. The collected answers
were organized to maintain objectivity and confidentiality, and each user was given a unique
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identification number. After all data were collected and organized, they were rechecked for
accuracy and further processing was performed to obtain statistical information.
Resources
The project utilized the Survey Monkey website to house the pre-recorded webinar. This
environment allowed participants to access the content at their discretion. The respondents were
encouraged to participate in a pretest knowledge evaluation, attend the webinar, followed by an
online posttest survey evaluation.
The technology needed for this project included a personal computer used for email
communication, scholarly project research, and webinar development. Computer software
programs utilized include Microsoft Word, PowerPoint, and SPSS statistical software. The
faculty advisor at Southern Adventist University served as a resource person to provide guidance
with this scholarly project. The principal researcher designed the study, gained approval from the
faculty advisor, as well as IRB approval, implemented the study, and has plans to disseminate the
project findings. The principal researcher solely funded the cost associated with this study.
Timeline of Project Phases
The timeline is described below.
1.

Summer 2020: Continue working on the rough draft of Chapters 1-3

2.

Fall 2020: Submit written proposal and request for IRB to Southern Adventist

University. Complete and submit Chapters 1-3. Finalize webinar and survey tool instrument.
3.

Winter 2021: Receive IRB approval. Implementation of the project, post on the

approved web pages, gather survey responses, organize survey data into Excel and perform
statistical analysis.
4.

Spring 2021 & Summer 2021: Complete chapters 4-5.
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5.

Fall 2021: Project presentation to Southern Adventist University School of Nursing.

Target Population and Setting
Target Audience and Subject Recruitment
The target audience of this study was RN and APRN healthcare workers who were
interested in enhancing their knowledge of LD. Subjects were recruited by electronic posting on
the approved social media web pages. The target population involved a convivence sample of
RN and APRN healthcare workers. The goal was to obtain a minimum sample size of 30
participants for this study.
Inclusion and Exclusion Criteria
Inclusion criteria were that participants had to be registered nurses, NP or NP students.
Exclusion criteria included minors, licensed practical nurses, nursing assistants, and non-licensed
healthcare providers.
IRB Approval
With faculty advisor approval, this study was then submitted for IRB approval through
Southern Adventist University. Approval for form A was granted on November 13, 2020
(Appendix H).
Ethical Considerations
The purpose of this DNP project was a technology-based approach to assessing and
enhancing the participant's knowledge of LD. Participation was voluntary and at any given point,
participants could opt out of the study. All responses to the surveys were confidential and
anonymous. No personal identifying information such as name, date of birth, social security
information, or place of employment was collected. No invasive procedures or collection of body
fluids, human tissue, or personal health information were done.
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The primary investigator completed CITI training, and a certificate of completion was
provided to the University before implementing the project.
The project maintained the protection of privacy during its entirety. The response surveys
were obtained from Survey Monkey, and the information was kept in a secure locked location.
Survey responses were only reviewed by the primary researcher and the faculty advisor. At the
conclusion of this project, all survey responses will be destroyed.
Risks and Benefits of Participation
The primary benefit of participation in this educational program is increased knowledge
of the dynamic components of Lyme disease. Research participants have the opportunity to
convey the knowledge acquired to their patients and potentially reduce the risk of LD and other
tickborne illnesses. The risk to the participants of this study may include a lack of understanding
of the material literacy due to unfamiliarity with Lyme disease. There were no economic or
physical risks associated with participating in this study. No physical task was performed or
evaluated. There were only minimal risks associated with this project, the risks associated are not
greater than those ordinarily encountered in the participants’ daily life (OSU, 2020).
Instruments and Measures
The evaluation tool was a pretest and posttest survey, which included fifteen items used
to evaluate the participant’s knowledge base before and after the educational webinar (Appendix
E & F). The tool was designed to rapidly examine the impact of the educational webinar on
aspects of LD regarding recognition of symptoms, risk perceptions, proper removal techniques,
and protective measures. The fifteen knowledge indicators were reviewed and approved by the
faculty at Southern Adventist University. Demographic data were collected separately (Appendix
G).
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Evaluation Plan
The education webinar contained a link to the pretest and posttest assessment tools on
Survey Monkey. Raw data obtained from the assessment tools were organized, and each entry
was double verified and cross-checked to prevent erroneous entries. After organization of the
data, the results were exported into IBM’s SPSS statistical software package for data analysis.
Responses that were missing or declined to answer were coded as such, and questions answered
were analyzed. A paired t-test was utilized to compare the means of pretest and posttest scores.
The statistical test results were aimed to determine if the project's goals were met by achieving
statistical or clinical significance. The statistical report shall determine any identifiable
relationships to validate or reject the scholarly project hypothesis statement.
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Chapter IV – Analysis of Results
Methods
The evaluation process of the educational webinar was measured through pretest and
posttest question scores that aided in detecting the participants’ level of knowledge regarding
diagnosis, treatment, and prevention of Lyme disease. Fifteen closed-end questions were
developed with learning objectives embedded in the pretest and posttest to compare the level of
understanding before and after the education webinar (Appendix E & F). Open-ended responses
were collected to evaluate the respondent’s reflection of key takeaway points that they could
incorporate into their practice. On April 21, 2021, the education webinar was made available on
the social media pages of: Nurse Practitioner Hospitalist Specialty Group, East Tennessee Nurse
Practitioners, Acute Care Nurse Practitioners, Show Me Your Stethoscope, and MICU Nurses.
Included in these recruitment announcements, participants received general information of the
educational project, the ability to evaluate the consent form as well as the links to the
pretest/webinar and posttest evaluations. This information was posted once a week for four
weeks. Closure of the participation occurred on May 21, 2021 with the education webinar and
surveys removed from all participating social media groups. Data were collected and organized
to measure if the project learning objectives were met.
Description of Key Variables
The identified dependent variables in the study were participants’ baseline knowledge of
LD and post-education intervention test scores. The identified independent variable in the study
was the online educational webinar that was provided to participants. The sample demographics
were analyzed through Survey Monkey. Once the data were organized, they were transferred to
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IBM Statistical Packages for Social Sciences (SPSS) software for analysis. SPSS Version 28 was
utilized.
Description of Sample
The online webinar’s completion rate was approximately eighty-four percent as thirtyseven individuals initiated the educational module, and thirty-one participants completed the
webinar and both evaluations. Thirty days of data were collected from RN, APRN, and LPNs
from across the US. Data obtained from two LPN participants was disregarded from this study
due to the exclusion criteria associated with this study. Pretest data from six participants were
omitted from this study for incompletion of posttest evaluation. Practice roles of participants
consisted of RNs 15 (52%) and APRNs 14 (48%). The level of education was relatively evenly
spread across associate’s, bachelor’s, master’s, and doctoral degrees. Of the participants, six
(20%) held doctoral degrees, while nine (31%) had associate degrees, see Figure 1.
The average age of RN participants was 35, and the average age of APRN was 45 years
old. RN participants primarily practiced in the inpatient medical-surgical staff nurse role; several
working in the emergency department. APRN participants were employed mainly as acute care
providers, however a number were working in family practice, emergency or other settings. See
Figures 2 and 3.
Description of Participant Experience with Lyme Disease
There was a low level of participants 3 (10%), who live or have ever lived in a tick
endemic area. When evaluating professional experience, seven participants (24.14%)
acknowledged they had been involved with diagnosing, treating, or have ever cared for a patient
with Lyme disease. Only four participants had contracted LD themselves or had family members
were diagnosed with Lyme or other tickborne diseases. Results are noted in Figure 4.
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Analysis of Project Questions
Research Question One
The first question examined geographical considerations that increase the risk of
contracting LD. Fifteen (50%) of participants correctly identified that the Northeastern and upper
Midwestern portions of the United States as high tick endemic areas. In the post-test
questionnaire, the number of participants who correctly identified the high endemic areas of LD
grew to 28 (93.3%) as a result of this educational webinar.
Research Question Two
This question evaluated the participants’ knowledge of the contributing agent responsible
for LD. Twenty-two (75.8%) correctly identified in the pretest that Borrelia burgdorferi was the
responsible agent. Upon completion of the webinar, the posttest revealed that 29 (100%)
participants had a correct response.
Research Question Three
The objective was to examine the participants’ knowledge of the typical size of the blacklegged tick/nymph responsible for transmitting Lyme disease. The pretest had various responses
except for zero participants felt that the typical size associated with transmission of LD is that of
a dime. The posttest scores noted that 9 (31%) failed to correctly identify that the typical size of
the black-legged tick/nymph is around the size of a poppy seed.
Research Question Four
This question showed enhanced knowledge from pretest scores of 4 (14%) to 28 (100%),
correctly scoring that transmission of the bacteria that causes LD requires a minimum of twentyfour hours of attachment time. One participant failed to answer this question.
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Research Question Five
The objective of this question was to examine the correlation of seasonal factors
associated with LD. In the pretest, only two participants answered incorrectly and all participants
in the posttest correctly identified that seasonal risk of acquiring LD occurs in late spring to
summer with the months of May to June being more prevalent.
Research Question Six
This objective involved examining the participants’ knowledge of the typical time span
from tick attachment to the clinical presentation of early localized symptoms of LD. Prior to the
webinar, 7 (23%) answered correctly by choosing the correct response of three to thirty days.
The posttest results demonstrated a significant increase of correct responses 26 (90%).
Research Question Seven
This question evaluated the participants’ knowledge that erythema migrans that measured
at least 5 cm is diagnostic criteria for LD. Pretest scores found that only 31% of healthcare
workers knew that erythema migrans were sufficient for the diagnosis of LD. These scores
correlate with the literature review that showed a knowledge gap in relation to clinical
presentation and diagnostic ability. Posttest results demonstrated knowledge enhancement with
100% responding correctly.
Research Question Eight
This objective was to identify participants’ clinical knowledge of Lyme arthritis
symptoms and what joints it typically affects. The pretest had a correct response rate by 15
(52%) of participants with the answer of the knees are most affects with pain and swelling. The
posttest scores showed improvement with 26 (89.6%) participants answering correctly.
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Research Question Nine and Ten
Question nine was a multiple-answer question that evaluated what type of patient should
not have serum lab evaluation for LD. These two questions aimed to determine the participants’
knowledge of diagnostic testing. Pretest results with all participants correctly selecting that
patients presenting with a low probability of infection based on environmental exposures of low
endemic areas and lack of clinical symptoms should not be tested. All participants, 29 (100%)
correctly selected those patients who present less than one week after exposure should not be
tested, and only 2 (6.6%) chose that you should not test those who are seeking a test cure
confirmation after being treated with antibiotic therapy. Posttest results demonstrated an increase
in knowledge, with 19 (65.5%) participants correctly identifying that you should not test those
who are seeing a test cure post-antibiotic therapy.
Question ten examined what type of patient could have false-negative serologic results
when evaluating for LD. The correct response was if obtained less than two weeks from
exposure, which was answered correctly by 18 (62%) participants in the pretest. Eleven (37.93)
answered incorrectly that if a patient is taking antibiotics, they have the probability of a false
negative result. Posttest scores demonstrated improvement with 26 (90%) answering correctly.
Research Question Eleven
Question eleven also examined the participants’ knowledge of diagnostic testing using
the two-step process recommended by the CDC. The pretest scores were 18 (62%) identified the
correct answer. During the posttest questionnaire, the number of participants who could correctly
identify that if the first step is negative, no further test steps should be taken grew to 28 (96.67%)
with only one incorrect answer.
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Research Question Twelve
This question sought to determine if participants acknowledge that LD is a reportable
disease. One participant omitted to answer this question, and 1 (3.6%) answered incorrectly in
the pretest, and 3 (10.34%) answered incorrectly in the post-test. Due to the incorrect answers
on the posttest, it is unclear if this was due to erroneous input or an inadequate knowledge base.
Research Question Thirteen
This question was to identify the healthcare workers’ knowledge of appropriate treatment
recommendations for an adult patient who was neither pregnant nor lactating. The responses
included amoxicillin, doxycycline, erythromycin, and rocephin. The pretest scores were 18
(64%) that doxycycline is the recommended antimicrobial agent with one participant omitting to
respond. The posttest score of 26 (90%) showed improvement.
Research Question Fourteen
This question was used to evaluate preventative strategies for LD. The correct answers
were a, b, and c which were to use insect repellent, wear long-sleeve shirts, tuck pants into socks
and eliminate brush, woodpiles, and tall grass in your yard. Knowledge of preventative measures
was apparent, with only one participant answering incorrectly in the pretest with answering that
you should receive an annual Lyme vaccine, and all participants responded correctly in the posttest.
Research Question Fifteen
This question evaluated if the participants felt they could safely and effectively remove
an embedded tick. All participants acknowledge they were skilled in the quick and correct steps
of proper removal.
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Practice Consideration
This portion of the posttest was used to examine if participants will consider LD in their
differential diagnosis list when evaluating patients with the clinical presentation and subjective
complaints to those of LD. All participants answered that they plan to include LD as a diagnostic
consideration.
Key Takeaway
This open-ended question examined if the webinar content had the potential to be
incorporated into their practice. The overall feedback received was positive with a significant
percentage of participants’ comments that the key takeaway point of this program was to
promote prevention strategies to their patients.
Statistical Analysis
After all assumptions were examined, a paired sample t-test was chosen to identify if
there was gained knowledge between the two survey responses. Data analysis demonstrated an
increase in mean scores between baseline knowledge and post-webinar surveys. The mean (SD)
increased from 65 (16.43%) to 96 (22.67%). The result of the t-test for the paired samples were
t(28)= -5.608, p <.001 and a Cohen’s d test showed a significant large effect, results are
presented in Figure 5. The statistical analysis proved to be significant.
To investigate the internal consistency of the pre and post-test, the Kuder-Richardson
(KR)-20 formula was used to gauge reliability. Results are presented in Figure 6. The pretest and
posttest were found to have good reliability coefficient values of KR-20 of .788 and .866,
respectively.
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Unintended Consequences
Before completing this project, the U.S. Food and Drug Administration (FDA) and the
CDC had approved a previous cleared test with the new indications to aid in the serological
diagnosis of Lyme. The new testing paradigm will consist of enzyme immunoassays (ELISA)
which are run concurrently rather than the previous two-step process that included the ELISA
and the Western Blot. This recently modified approach will allow clinicians a new test option
that is more streamlined and is easier to interpret (APHL, 2021). Unfortunately, these new
guidelines for testing were not included in the educational webinar.
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Chapter V – Discussion of Findings
Summary
Lyme disease is a growing public health concern in the United States. The CDC
previously estimated that 30,000 Americans get Lyme disease each year. Recently released data
based on insurance records suggest that around 476,000 Americans were diagnosed and treated
each year for Lyme disease (CDC, 2019). Diagnosing Lyme disease is problematic due to the
diversity of signs and symptoms as well as a reliable rapid test during the early stages.
If left undiagnosed or improperly treated, there is a potential for chronic to life-threatening
complications.
Healthcare workers play a critical role in reducing and or preventing health complications
associated with Lyme disease, but a knowledge gap is present. In general, the literature is
disproportionately focused on physician knowledge and practice patterns. When APRNs were
included in a study, the APRNs represented only a small percentage of providers studied and
were noted to have less than robust knowledge scores of all providers represented. A 2014
survey conducted on U.S. healthcare providers which included physicians who specialize in
family practice, pediatrics, dermatology, obstetrics as well as nurse practitioners, reported that
over 30% of participants did not feel knowledgeable of Lyme and other tickborne diseases (Bret
et al., 2014). No studies were identified that exclusively assessed RN or APRN healthcare
workers.
This clear gap in the literature demonstrated an apparent need for increasing the
knowledge of Lyme disease in healthcare workers. An online webinar was created to distribute
information on recognition, diagnosing, treating and preventing Lyme disease for healthcare
workers.
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Outcomes of Research
This project sought to examine the impact of a Lyme disease education program on
healthcare workers. Will posttest scores be significantly increased from pretest scores following
a Lyme disease education program for both RN and APRN providers?
The goals were to determine if healthcare workers who participate in a Lyme disease
educational program will demonstrate increased knowledge of epidemiology, disease
manifestations, tick removal techniques. The project also sought to give information that RN and
APRNs could use to increase knowledge in diagnosing, treating, and preventing Lyme disease.
The literature review exposed that a knowledge gap was present in relation to diagnosing,
treating and preventing Lyme disease (Brett et al., 2014). The results of this study correspond
with the exposed knowledge gap, with low scores ranging between 14% - 75% on the content
related questions. Participants scored the lowest on the minimal attachment time required to
transmit the Lyme disease bacteria within the pretest. In the pretest, only 4 (14%) of participants
correctly identified the minimum is twenty-four hours. The posttest showed a complete
understanding of the duration of tick attachment time in relation to the transmission of the Lyme
bacteria, with all 29 (100%) participants answering correctly. Findings ranging from 34% to 56%
from studies that involved Connecticut, Arkansas, and West Virginia physicians and
practitioners reported they were not aware that EM rash itself alone was diagnostic criteria
(Nesgos et al., 2021). This finding is consistent with the knowledge gap found in this study.
Pretest scores found that only 31% of healthcare workers knew EM was sufficient for diagnosis.
Posttest results demonstrated knowledge enhancement with 100% of participants responding
correctly. Study knowledge varied among West Virginia providers in regards to the signs and
symptoms surrounding the stages of Lyme disease ranging from 50.8% to a high of 70% (Nesgos
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et al., 2021). Pretest scores of this study noted a low understanding of symptoms involved in the
stages of Lyme disease, with 23% of respondents with correct answers. Posttest results
demonstrated a 67% increase in correct responses. This question had a reasonably low increase
in knowledge advancement, perhaps the material contained within the webinar required more
clarity.
A concerning weakness is apparent in the question examining whether participants
acknowledge that Lyme is a reportable disease. In the pretest only one participant failed to
correctly identify that LD is a reportable disease. In the posttest 3 participants answered
incorrectly. Due to the incorrect answers on the posttest it is unclear if this was due to erroneous
input or an inadequate knowledge base.
Limitations
This scholarly project has numerous associated limitations. One limitation was not
including medical assistants, physician assistants, and licensed practical nurses. This study
focused on RN and APRN subjects and did not consider the valuable role that these other
medical professionals contribute.
A second limitation is the reliability of the survey data collected. Respondents may not
have provided accurate, honest or thoughtful, conscientious responses. Closed-ended questions
options could have led to unclear data because specific answer options could be interpreted
differently by participants.
A significant limitation of this project was the limited access to the targeted population.
The sample size for this project is limited to those participants willing to answer the survey
questions and view the webinar, which could create self-selection bias. For those participants
who accepted the survey invitation and consent, there is always the possibility of multiple
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responses from the same person simply because no personal identifying factors such as an email
address were required to submit the consent to participate or complete the surveys, for which is
problematic for random sampling. Participants were asked to assign themselves a unique code
name or number. This extra step was beneficial to compare the pre and post-test responses.
However, requiring this additional step could have reduced the response rate.
Another limitation was the three steps (demographic/pretest, viewing webinar and
posttest evaluations) and the twenty minutes required to view the webinar. Five participants
completed the pretest but did not complete the posttest evaluation. It is unclear if technical
difficulties hindered completion or opted out due to lack of interest or the amount of time
required to view the webinar.
Recommendations for Future Research
Future research is warranted to continue to educate both patients and providers about
Lyme and other tickborne diseases. The results of this study indicate the need for further research
on recognition, treatment, and prevention of LD for healthcare providers. This study provides a
foundation for additional studies such as projects tailored toward individual subsets of medical
professions such as medical assistants, LPN and physician assistants. Additionally, this study
should be expanded to those healthcare workers who practice in the outpatient settings for a
more balanced blend of participants. More research is recommended to discover further how to
best enhance the knowledge of LD for healthcare workers.
Implications for Practice
Despite the limited amount of participation in this scholarly project, the statistical
findings indicated the healthcare workers obtained knowledge to effectively promote protective
measures, utilize appropriate diagnostic tests, and various other skills. The knowledge gap
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observed in this project has improved, and those who participated have the potential to enrich
their patient population and thus promote health within their community.
A portion of the posttest was used to examine if participants will consider LD in their
differential diagnosis list when evaluating patients with the clinical presentation and subjective
complaints similar to those of LD. All participants answered that they plan to incorporate LD as
a diagnostic consideration.
An opened-ended question was incorporated within the posttest to examine if the
webinar's content had the potential to be incorporated into the healthcare worker's practice. The
overall feedback received was very positive, with a significant percentage of participants’
comments that the key takeaway from this webinar was to promote prevention strategies to their
patients.
This project demonstrates short-term bridging of the knowledge gap. This research shows
an application in practice, and an educational project's long-term benefits like this are needed.
This could be accomplished by three or six months of follow-up with participants to determine
retention of accurate information. To determine benefits to patient outcomes is more
complicated. A chart audit for keywords or symptoms as a chief complaint might provide clues
to whether or not LD was considered. Because differential diagnoses are not a required aspect of
documentation, this may be difficult to determine. The use of electronic health records allows for
search processes that might facilitate the study of provider use of LD knowledge.
Long-term knowledge retention in relation to practice change and improvement of patient
outcome of participants was impossible to obtain and measure due to the time constraints within
the design of this project. Participants who practice in high tick endemic areas should stay
abreast with the latest evidence-based practice knowledge by, visiting the CDC as well as their
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state of practice website to evaluate if there are any changes in diagnosis or treatment
recommendations as well as participate in webinars or CME activities that focus on Lyme
disease.
Conclusion
This educational webinar on Lyme disease contributed to increased knowledge,
awareness, patient education, and personal involvement in health change of registered nurses and
advanced practice registered nurses. The quantitative responses to this educational webinar
confirm that this scholarly project has contributed to the body of nursing knowledge and aim of
promoting health and risk reduction strategies.
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RESEARCH QUESTION
What is the impact of an Lyme disease educational
program on RN and APRN healthcare workers?

LYME DISEASE
A E D U C AT I O N A L W E B I N A R F O R H E A LT H C A R E
PROVIDERS
PRESENTED BY:

DONITA BLANKEN-LITTLE
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INTRODUCTION & HISTORY

OBJECTIVES

Figure 1
Blacklegged Tick

ØKnowledge about the epidemiology of Lyme disease
ØKnowledge of the disease manifestations and course to include
chronic complications of Lyme disease

What is Lyme Disease?

ØAbility to individualize tick-bite treatment plans
ØSkill in safe removal of an embedded tick
ØCommitment to evidence-based Lyme disease prevention and
treatment to patients

Note. Adapted from Factsheet, CDC,
https://www.cdc.gov/lyme/resources/
toolkit/factsheet ) .

ØFamiliarization with Lyme disease education and referral resources

3

4

ETIOLOGY

Figure 3

VECTOR CYCLE

Lifecycle of blacklegged ticks
Figure 2

Lyme disease is spread through a bite of
infected ticks.
In the Northeastern and mid-Atlantic the
blacklegged tick or deer ticks spreads the
disease.
The western blacklegged tick spreads
disease on the Pacific coast.

Tick Life Stages

Note. Adapted from Transmission, CDC,
https://www.cdc.gov/lyme/transmission) .

5

Note. Adapted from Lifecycle of Blacklegged Ticks, CDC (https://www.cdc.gov/lyme/transmission).
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INCIDENCE

EPIDEMIOLOGY
Figure 4
Figure 5

Reported cases of Lyme Disease, 2018

Data and Surveillance

Note. Adapted from Lyme Disease Maps, CDC (https://www.cdc.govv/lyme/datasurveiliance/maps).

Note. Adapted from Lyme Disease Maps: Historical Data, 2019, CDC (https://www.cdc.gov/lyme/stats/maps) .
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8

CLINICAL FEATURES
EARLY LOCALIZED INFECTION

TRANSMISSION
Figure 8

Transmission of Lyme disease can only occur through a bite of an infected tick.

Early Lyme Symptoms

The infect tick must be attached 24 hours of more for transmission to occur.
There is no evidence of person to person transmission.
Figure 7
B. Burgdorferi

Note. Adapted from Signs and Symptoms of Untreated Lyme Disease, CDC (https://www.cdc.gov/lyme/signs_symptoms
).

Note. Adapted from Disease or Condition of the Week Lyme, 2019
(https://www.cdc.gov/dotw/lyme-disease).
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10

Figure 9

EARLY DISSEMINATED DISEASE

ERYTHEMA MIGRANS

Erythema Migrans

Figure 10
Late Signs and Symptoms of Lyme disease

Seldom painful or
Pruritic
Typically appears in
3 to 30 days

Note. Adapted from Signs and Symptoms of Untreated Lyme Disease, CDC (https://www.cdc.gov/lyme/signs_symptoms).

Note. Adapted from Lyme Disease Rashes and Look-alikes , CDC (https://www.cdc.gov/lyme/signs_symptoms) .
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12
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DISSEMINATED DISEASE

DIAGNOSIS

Figure 11

Figure 12

Lyme Carditis

Target Lesion

Note. Adapted from Lyme Carditis, CDC (https://www.cdc.gov/lyme/sign_symptoms/lymecarditis .

13

Presence of Erythema Migrans is diagnostic criteria for Lyme disease
If area is at least 5 cm

Note. Adapted from Symptoms of Tick-borne Illness , CDC (https://www.cdc.gov/ticks/symptoms) .
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DIAGNOSIS

DIAGNOSIS

Figure 13
Two-Tiered Testing Decision Tree

A negative test early in infection is meaningless as the antibody response takes time to
develop (one to three weeks).
False Positives
The biggest problem with these antibody tests is that they do not give information on
whether or not infection is present at the time of the test.
Culture: The only way of knowing this for sure is if a person is still infected with a living
spirochete is if the organism can be cultured. Unfortunately culturing Lyme disease is nearly
impossible after the initial infection because the spirochete doesn't stay in the blood or
spinal fluid very long.
PCR: This test looks for evidence of the DNA of Borrelia burgdorferi in the blood or spinal
fluid. This test however is not very sensitive for Lyme disease because the genetic material
of the spirochete doesn't stay in the blood or spinal fluid very long,
Note. Adapted from Signs and Symptoms of Untreated Lyme Disease, CDC (https://www.cdc.gov/lyme/healthcare/clinician_twotier ).
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TREATMENT

RECOMMENDATIONS
Table 14

ØLyme disease is notifiable disease. However reporting nationally
notifiable disease and conditions isn’t required by federal law and
varies from state to state.

Treatment Lyme Disease

ØEvaluate for co-infections Anaplasmosis and Babesiosis
ØEvaluate Diet

Note. Adapted from Signs and Symptoms of Untreated Lyme Disease, CDC (https://www.cdc.gov/lyme/treatment) .
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POST TREATMENT LYME DISEASE
SYNDROME

ANTIBIOTIC PROPHYLAXIS

ØMost cases of Lyme disease can be cured with a 2-4 week course of
oral antibiotics, patient can sometimes experience pain, fatigue,
difficulty thinking that last for more than 6 months after completion
of treatment. This is known as post treatment Lyme disease (PTLDS)
or also known as chronic Lyme disease (CDC, 2019).

ØProphylaxis is not recommended for everyone.

ØWhy some patients experience PTLDS is unknown.

ØAll patients who have removed a tick regardless of whether they
have received prophylaxis or live in or travel to endemic areas should
be monitored for signs and symptoms of Lyme and other tick-borne
diseases for 30 days (Bratton, et al., 2008).

ØIn certain circumstances a single dose of doxycycline after a tick bite
may reduce your risk of Lyme disease if you live in an area where
Lyme disease is common.

ØStudies suggest that 10 to 20% of patients who were diagnosed with
characteristic bulls eye rash and completed antibiotics continued to
have symptoms of fatigue, HA, arthralgia and difficult with memory
long after treatment (Marques, 2008)
ØUnfortunately there is no proven treatment for PTLDS.
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Table 15
Prevention

CREATE A TICK-SAFE ZONE

Prevention

ØMake your yard less attractive for ticks
ØTall grasses
ØWood chips/gravels
ØLeaves

Note. Adapted from Signs and Symptoms of Untreated Lyme Disease, CDC (https://www.cdc.gov/lyme/prev/on_people) .

21

22

Figure 16

VACCINE

Tick removal

ØLYMErix
ØVLA15
ØLyme PrEP

N ote. Adapted from Signs and Sym ptom s of Untreated Lym e Disease, CDC (https://w w w .cdc.gov/lym e/resources/FS-G uidance-for-Clinicians-Patientsafter-TickBite ).
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CONSULTATION

TENNESSEE VALLEY

Infectious disease should be consulted if neurologic and cardiac
conditions are present.

Figure 17
Blacklegged Tick Map

Recurrent arthritis
Post-treatment Lyme Disease Syndrome

Note. Adapted from Blacklegged Tick (Ixodes scapularis),
CDC(https://www.cdc.gov/ticks/maps/blacklegged).
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TAKE AWAY POINTS

CONCLUSION

Endemic areas: Northeastern and Upper Midwestern United States
Presence of erythema migrans is diagnostic criteria for Lyme disease
Lyme disease is caused by Borrelia burgdoferi
Minimum attachment duration for transmission is > 24 hours
Lyme disease is a reportable disease
Serologic testing for Lyme disease is the two-tiered testing method (ELISA & Western blot) if ELISA is negative
there is no need for the western blot.
False negative results if performed to soon after exposure. Typically obtain serology in 2-3 weeks.
Treatment for Lyme disease typically is doxycycline for non-lactating & non-pregnant adults
prophylactic antibiotic’s are not recommend for everyone
Remove an attached tick as soon as possible with tweezers
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Appendix B. CDC Request Permission for Image and Material Use

To whom it may concern,
I am in the Doctor of Nursing Practice program at Southern Adventist University and I am developing an
educational program on prevention, recognition and promotion of protective measures of Lyme disease to
healthcare providers. I would like to utilize general text information, images and publication developed
by the CDC that are found on the CDC website.
Sincerely,

Donita Blanken-Little
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Appendix C. CDC Image and Materials Permission for Use

Hi Donita,

Thank you for your interest in using CDC materials. Please see below for CDC's copyright information.

General text information, publications available for download, and graphs developed by CDC and
presented on CDC's website are works of the United States Government and are in the public domain.
This means that they are meant for public use and are not subject to copyright law protections. Permission
is not required for use of public domain items. But, CDC does ask that you credit the original institution
and contributor, when known, whenever the item is used in any publicly distributed media.

You are also free to adapt and revise these materials, provided the information is distributed free of cost;
however, you must remove the CDC name and logo if changes are made.

Best regards,
CDC News Media
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Appendix D. Consent Form
Dear Healthcare Provider,
My name is Donita Blanken-Little. I am in the Doctor of Nursing Practice program at Southern
Adventist University and I am conducting an educational webinar to increase knowledge of Lyme disease
for healthcare providers. The project is titled “Lyme Disease Essential for Healthcare Workers”. By
participating in this education project, you will have the opportunity to gain awareness and knowledge of
the signs and symptoms as well as protective measure associated with Lyme disease.
If you choose to participate in this education project, you will be asked to complete a short survey
including questions on demographics, a pretest, participate in the webinar on Lyme disease and complete
a post-test evaluation.
The webinar is self-directed and should take approximately 20 minutes to complete. Participation
in this project is strictly voluntary and you can opt out at any given time. You will not have to provide
any personal identification.
By clicking agree below you agree to participate in this research survey and you will be taken to
the first question.
Thank you for your participation.
Donita Blanken-Little, APRN, AGACNP-BC, DNP-Student

Agree
Disagree
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Appendix E. Pre-test Survey Questions
1.

Lyme disease is most endemic in what regions of the United States
A.
Pacific Coast
B.
Southwestern
C.
Northeastern & upper Midwestern
D.
Southern

2.

Which of the following microorganism is the causative agent of Lyme disease
A.
Borrelia burgdorferi
B.
Treponema pallidum
C.
Shigella sonnei

3.

Lyme disease is transmitted through the bite of blacklegged tick nymphs, which are around the
size of
A.
A poppy seed
B.
A sesame seed
C.
A pencil eraser
D.
A dime

4.

Transmission of the bacteria that causes Lyme disease requires the minimum hour of attachment
A.
12 hours
B.
24 hours
C.
36 hours

5.

The peak incidence of Lyme disease occurs
A.
Late spring to summer May-July
B.
Fall September-November
C.
Winter December-February

6.

Early localized symptoms of Lyme disease such as erythema migrans, fatigue, fever, neck
stiffness, headache, myalgia & arthralgia typically appear within how may days from tick
attachment.
A.
5-7 days
B.
3-30 days
C.
5-10 days

7.

A patient presents with erythema migrans that measures 5 cm but has no recall of a tick bite.
Would this presentation be sufficient for diagnosis of Lyme disease?
A.
Yes
B.
No

8.

The pain and swelling of Lyme arthritis typically affects which joints
A.
Back
B.
Knee
C.
Hands and wrist
D.
Shoulder
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9.

Who should not be tested for Lyme disease
Select all that apply
A.
Those with a low probability of infection based on environmental exposures, low
endemic areas and lack of clinical symptomology
B.
Presenting less than one week after tick exposure
C.
Seeking a test cure for treated Lyme disease
D.
A known tick exposure one month prior, complains of a headache and arthralgia

10.

False negative serologic testing occurs with Lyme disease if
A.
If obtained less than two weeks from exposure
B.
If patient is taking antibiotics
C.
If the patient did not fast before having their blood drawn

11.

Serologic testing for Lyme disease requires a two-step process; the first step involves a
quantitative screening with an EIA. If the results are negative is further testing recommended?
A.
Yes
B.
No

12.

Lyme disease is a reportable disease
A.
Yes
B.
No

13.

What is the drug of choice for treatment of Lyme disease in non-pregnant non-lactating adults?
A.
Amoxicillin
B.
Doxycycline
C.
Erythromycin
D.
Rocephin

14.

Prevention strategies for Lyme disease include
Select all that apply
A.
Use insect repellent
B.
Wear long sleeve shirt, socks and tuck pants into socks
C.
Eliminate brush, woodpiles and tall grass in your yard
D.
Receive an annual Lyme vaccine

15.

I am able to properly remove an embedded tick
A.
Yes
B.
No
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Appendix F. Post-Test Survey Questions
1.

Lyme disease is most endemic in what regions of the United States
A.
Pacific Coast
B.
Southwestern
C.
Northeastern & upper Midwestern
D.
Southern

2.

Which of the following microorganism is the causative agent of Lyme disease
A.
Borrelia burgdorferi
B.
Treponema pallidum
C.
Shigella sonnei

3.

Lyme disease is transmitted through the bite of blacklegged tick nymphs, which are around the
size of
A.
A poppy seed
B.
A sesame seed
C.
A pencil eraser
D.
A dime

4.

Transmission of the bacteria that causes Lyme disease requires the minimum hour of attachment
D.
12 hours
E.
24 hours
F.
36 hours

5.

The peak incidence of Lyme disease occurs
D.
Late spring to summer May-July
E.
Fall September-November
F.
Winter December-February

6.

Early localized symptoms of Lyme disease such as erythema migrans, fatigue, fever, neck
stiffness, headache, myalgia & arthralgia typically appear within how may days from tick
attachment.
A.
5-7 days
B.
3-30 days
C.
5-10 days

7.

A patient presents with erythema migrans that measures 5 cm but has no recall of a tick bite.
Would this presentation be sufficient for diagnosis of Lyme disease?
A.
Yes
B.
No

8.

The pain and swelling of Lyme arthritis typically affects which joints
A.
Back
B.
Knee
C.
Hands and wrist
D.
Shoulder
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9.

Who should not be tested for Lyme disease
Select all that apply
A.
Those with a low probability of infection based on environmental exposures, low
endemic areas and lack of clinical symptomology
B.
Presenting less than one week after tick exposure
C.
Seeking a test cure for treated Lyme disease
D.
A known tick exposure one month prior, complains of a headache and arthralgia

10.

False negative serologic testing occurs with Lyme disease if
A.
If obtained less than two weeks from exposure
B.
If patient is taking antibiotics
C.
If the patient did not fast before having their blood drawn

11.

Serologic testing for Lyme disease requires a two-step process; the first step involves a
quantitative screening with an EIA. If the results are negative is further testing recommended?
A.
Yes
B.
No

12.

Lyme disease is a reportable disease
A.
Yes
B.
No

13.

What is the drug of choice for treatment of Lyme disease in non-pregnant non-lactating adults?
A.
Amoxicillin
B.
Doxycycline
C.
Erythromycin
D.
Rocephin

14.

Prevention strategies for Lyme disease include
Select all that apply
A.
Use insect repellent
B.
Wear long sleeve shirt, socks and tuck pants into socks
C.
Eliminate brush, woodpiles and tall grass in your yard
D.
Receive an annual Lyme vaccine

15.

I am able to properly remove an embedded tick
A.
Yes
B.
No

16.

Will Lyme disease be on your differential diagnosis list
A.
Yes
B.
No

17.

What is one key take away from this program that you will incorporate into your practice?

65
Appendix G. Demographic Survey
1.

What is your age?
_________________________

2.

What is the highest level of education you have completed?
Vocational degree certificate/diploma
Associates degree
Bachelors’ degree
Masters’ degree
Doctoral degree

3.

How many years have you been practicing in the field of nursing?
RN
______
APRN ______

4.

For nurse practitioners only. Which of the following best describes your practice.
Family/ Outpatient clinic
Emergency Department
Acute/Critical Care/ Inpatient
Other

6.

For RN only. Which of the following best describes your practice.
Med-Surgical/Staff nurse
Emergency Department
Outpatient clinic
School/Camp nurse
Pediatric
Other

7.

Do you live or have ever lived in a tick endemic area
Yes
No

8.

Have you diagnosed/treated or been involved in the care of a patient with Lyme disease?
Yes
No

9.

Have you or any of your family members been diagnosed with Lyme or any other tick-borne
disease.
Yes
No
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Appendix H. IRB Approval
November 13, 2020
Principal Investigator: Donita Blanken-Little
Research Project: Lyme disease essentials for healthcare workers
IRB Tracking Number: 2020-2021-022
Dear Donita,
It is a delight to inform you that your research protocol titled “Lyme disease essentials for healthcare workers,“
has been approved by the Southern Adventist University Institutional Research Board according to the proposal.
You are now authorized to proceed with the project as outlined. This approval expires May 31, 2021.
As a principal researcher, you have the ultimate responsibility for the conduct of the study, adherence to ethical
standards, and protection of the rights and welfare of human participants. As you proceed with your research, you
are expected to:
1) Conduct the study according to the approved protocol.
2) Make no changes to the approved study. If changes are necessary, proceed with one of the following:
a) For minor changes to this protocol, please notify IRB by submitting an IRB Form B and proceed after
its approval.
b) For substantial changes, submit a new IRB Form A and proceed after its approval.
3) Use the approved procedure and forms for obtaining informed consent and data.
4) Promptly report any significant adverse events to the IRB within five working days of occurrence using an
Adverse Report Form.
All forms must be submitted to irb@southern.edu.
We wish you many blessings as you move forward with this study and look forward to reading your findings when
they are ready. If there is anything else we can do to assist you with this research study, please contact us.
Always in His service,

Responsibility – Input – Strategic – Learner – Achiever
“I applied my mind to study and to explore by wisdom all that is done under the heavens…” - Ecclesiastes 2:13“Research is to see what
everyone else has seen and to think what nobody else has thought.” - Albert Szent-Gyorgyi

